Fundraising FoxOMX Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Syndexsyndex.bioFeb 2025 · $15.5M
Syndex develops mcPCR (methyl copying PCR), a proprietary platform technology that amplifies DNA while preserving methylation patterns, addressing the challenge of low DNA levels in clinical samples.
BiotechDeep TechMedical DevicesSanta Monica, US
Geoff Smith(Founder & CEO)inJason Betley(Chief Product Officer)in
Co-investors+ND CapitalARCH Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.